All the gene therapy are done on human and can be done in human and classified into following four types.
(1)Somatic gene therapy:- The genetic defects are corrected in somatic cells of the body. It was initially formulated for the treatment of monogenetic defects, but now holds promises for a wide range of disorders such as cancer, neurological disorders, heart diseases and infectious diseases(Table 1).sufficient expertise in performing successful gene transfer in somatic cells is required before carrying out gene manipulation in human.
Table 1.Genetic disorder
and acquired diseases amenable to gene therapy.
Diseases |
Therapeutic
agent |
Strategy |
Vector |
Target cell/tissue |
|
Genetic disorder |
|
|
|
|
|
Cystic fibrosis |
CFTR |
In vivo |
Adenovirus |
Nasal epithelium |
|
Familial hypercholesterolaemia |
LDL |
In vivo |
Cationic lipids |
Nasal epithelium |
|
SCID | ADA |
Ex vivo |
Retrovirus |
T cell |
|
Heamophilia |
Factor 8/9 |
In vivo |
Retrovirus |
Hepatocytes,skin,muscles |
|
DMD |
Dysterophine |
In vivo |
Retrovirus |
Skeletal muscles |
|
|
|
|
|
|
|
Acquired disorder |
|
|
|
|
|
Alzheimer’s disease |
NGF |
Ex vivo |
Retrovirus |
Tumour cells |
|
AIDS |
HIV agent |
Ex vivo |
Retrovirus |
T cells |
|
RevM10 |
Ex vivo |
Retrovirus |
Hepatocyte |
||
Cancer |
Cytokine |
Ex vivo |
Retrovirus |
Hepatopoitic stem cells |
|
Interleukins, |
Ex vivo |
Retrovirus |
Tumour cells |
||
HSV-TK |
Ex vivo |
Retrovirus |
Tumour cells |
||
HLA |
In vivo |
Cationic lipid |
‘’ |
||
Tumour
suppressor gene |
In vivo |
Cationic lipid |
‘’ |
||
Cardiovascular disease |
tPA |
In vivo |
Adenovirus |
Tumour cells |
|
Parkinson’s disease |
TH |
Ex vivo |
Retrovirus |
Fibroblast |
|
(2) Germ line gene therapy.
The functional gene are introduce into the germ cell for correction of genetic
defects in the offspring. This therapy is being carried out in laboratory and
farm animals. However, it has not been
attempted in humans due to technical and ethical problems. One of this type is
embryo therapy where embryos are diagnosed for genetic defects. If any such
disease is present the patient are adevised for embryo therapy or abortion. In
young embryo a functional gene is transferred through microinjection technique.
(3) enhancement genetic engineering. This type of
gene transfer is done for the improvement of a specific trait in animals; for
example introduction of growth hormone gene in to increase height. It is being
carried out in laboratory and farm animals.
(4) Eugenic genetic engineering.
Novel gene can be introduced in humans to alter or improve complex trait such
as intelligence and personality. This type of therapy is not being attempted in
humans because it is far away from technical capabilities, and ethical
problems.
In 1990, for the first time , Michal Blease and w.french Andresco of national institute of health,Bethesda , U.S.A attempted gene therapy on a human patient. A four year old girl was suffering from ‘severe combined immunodeficiency’(SCID). This disease is caused by a faulty gene which express the enzymes adenosine deaminase (ADA). Deficiency of ADA result in the production of chemical which selectively distroyes the T- and B-cells of immune system. Finally, the patient die. The scientist finally introduce a healthy ADA gene in the body of girl who protect her immune system from damage. This successful trail has given the signal for the draw of new era in the field of medical science.
what is DNA and Chemical nature of DNA ?
Units of Gene and How it was discovered ?
What are types of Gene therapy ?
What is Data Base and classification of Data Base ?
DNA replication or Blotting techniques ?
What is Overlapping Genes or Genes within Genes ?
How infertility in Haman occur ( male and female ) ?
Super... Information about biotechnology keep it and grow up
ReplyDelete